Literature DB >> 17410810

Symptom control trials: a 20-year experience.

Charles L Loprinzi1, Debra L Barton, Aminah Jatoi, Jeff Sloan, Jim Martenson, David Steensma, Ravi Rao, Paul Novotny, Amit Sood, Axel Grothey, Lori Minasian, Harold Windschitl.   

Abstract

Symptoms related to cancer and/or cancer therapy are a prominent consideration in cancer patients; multiple options have been proposed to alleviate these problems. The US National Cancer Institute (NCI) Community Clinical Oncology Program (CCOP) has mandated that CCOP participant institutions be involved with cancer control trials in addition to cancer treatment trials. Through such efforts, scientifically sound symptom control clinical trials are being conducted to determine the effectiveness of promising agents. In this article, the authors provide an update of clinical trial outcomes regarding 13 symptom and symptom complexes related to cancer and/or cancer therapy, emphasizing that publication of both positive and negative study results is important to separate what works from what does not.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17410810

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


  9 in total

1.  A novel role for CD4+ T cells in the control of cachexia.

Authors:  Zhuangzhi Wang; Chunfang Zhao; Rosa Moya; Joanna D Davies
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

Review 2.  Future cancer research priorities in the USA: a Lancet Oncology Commission.

Authors:  Elizabeth M Jaffee; Chi Van Dang; David B Agus; Brian M Alexander; Kenneth C Anderson; Alan Ashworth; Anna D Barker; Roshan Bastani; Sangeeta Bhatia; Jeffrey A Bluestone; Otis Brawley; Atul J Butte; Daniel G Coit; Nancy E Davidson; Mark Davis; Ronald A DePinho; Robert B Diasio; Giulio Draetta; A Lindsay Frazier; Andrew Futreal; Sam S Gambhir; Patricia A Ganz; Levi Garraway; Stanton Gerson; Sumit Gupta; James Heath; Ruth I Hoffman; Cliff Hudis; Chanita Hughes-Halbert; Ramy Ibrahim; Hossein Jadvar; Brian Kavanagh; Rick Kittles; Quynh-Thu Le; Scott M Lippman; David Mankoff; Elaine R Mardis; Deborah K Mayer; Kelly McMasters; Neal J Meropol; Beverly Mitchell; Peter Naredi; Dean Ornish; Timothy M Pawlik; Jeffrey Peppercorn; Martin G Pomper; Derek Raghavan; Christine Ritchie; Sally W Schwarz; Richard Sullivan; Richard Wahl; Jedd D Wolchok; Sandra L Wong; Alfred Yung
Journal:  Lancet Oncol       Date:  2017-10-31       Impact factor: 41.316

3.  N-Acetylcysteine Rinse for Thick Secretion and Mucositis of Head and Neck Chemoradiotherapy (Alliance MC13C2): A Double-Blind Randomized Clinical Trial.

Authors:  Terence T Sio; Miran J Blanchard; Paul J Novotny; Samir H Patel; Jean-Claude M Rwigema; Levi D Pederson; Lisa A McGee; Mauricio E Gamez; Grant R Seeger; James A Martenson; Yvonne Grover; Michelle A Neben Wittich; Yolanda I Garces; Robert L Foote; Robert C Miller; Michele Y Halyard
Journal:  Mayo Clin Proc       Date:  2019-08-09       Impact factor: 7.616

4.  Unanticipated toxicities from anticancer therapies: survivors' perspectives.

Authors:  Mona Gandhi; Karen Oishi; Beth Zubal; Mario E Lacouture
Journal:  Support Care Cancer       Date:  2009-12-03       Impact factor: 3.603

5.  Why providers participate in clinical trials: considering the National Cancer Institute's Community Clinical Oncology Program.

Authors:  Ann Scheck McAlearney; Paula H Song; Kristin L Reiter
Journal:  Contemp Clin Trials       Date:  2012-08-19       Impact factor: 2.226

Review 6.  North Central Cancer Treatment Group--achievements and perspectives.

Authors:  Axel Grothey; Alex A Adjei; Steve R Alberts; Edith A Perez; Kurt A Jaeckle; Charles L Loprinzi; Daniel J Sargent; Jeff A Sloan; Jan C Buckner
Journal:  Semin Oncol       Date:  2008-10       Impact factor: 4.929

7.  Effect of saffron on liver metastases in patients suffering from cancers with liver metastases: A randomized, double blind, placebo-controlled clinical trial.

Authors:  Azar Hosseini; Seyed Hamed Mousavi; Anis Ghanbari; Fatemeh Homaee Shandiz; Hamid Reza Raziee; Masoud Pezeshki Rad; Seyed Hadi Mousavi
Journal:  Avicenna J Phytomed       Date:  2015 Sep-Oct

8.  Chemotherapy and dietary phytochemical agents.

Authors:  Katrin Sak
Journal:  Chemother Res Pract       Date:  2012-12-20

9.  A novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathy.

Authors:  Lauren E Ta; James D Schmelzer; Allan J Bieber; Charles L Loprinzi; Gary C Sieck; Jill D Brederson; Philip A Low; Anthony J Windebank
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.